The effect of sex on endothelial function responses to clamped hyperglycemia in type 1 diabetes

Hypertension Research

Volumn 37, Issue 3, 2014, Pages 220-224

  Har, Ronnie ^a   Lai, Vesta ^a   Cherney, David ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

endothelial function; gender; hyperglycemia; type 1 diabetes

Indexed keywords

ANGIOTENSIN II; HEMOGLOBIN A1C;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; BRACHIAL ARTERY; FEMALE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; ULTRAFILTRATION; ULTRASOUND; VASODILATATION; YOUNG ADULT;

BLOOD GLUCOSE; BRACHIAL ARTERY; DIABETES MELLITUS, TYPE 1; ENDOTHELIUM, VASCULAR; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEMODYNAMICS; HUMANS; HYPERGLYCEMIA; MALE; REGIONAL BLOOD FLOW; SEX CHARACTERISTICS; VASODILATION; YOUNG ADULT;

EID: 84895824825     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.136     Document Type: Article

References (44)

1. Mangili R, Deferrari G, Di Mario U, Giampietro O, Navalesi R, Nosadini R, Rigamonti G, Spezia R, Crepaldi G. Arterial hypertension and microalbuminuria in IDDM: the Italian Microalbuminuria Study. Diabetologia 1994; 37: 1015-1024.
2. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, LaPorte RE, Kuller LH. Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 1990; 39: 1116-1124.
3. Jacobsen P, Rossing K, Tarnow L, Rossing P, Mallet C, Poirier O, Cambien F, Parving HH. Progression of diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int Suppl 1999; 71: S101-S105.
4. Breyer JA, Bain RP, Evans JK, Nahman NS Jr., Lewis EJ, Cooper M, McGill J, Berl T. Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. Kidney Int 1996; 50: 1651-1658.
5. Coonrod BA, Ellis D, Becker DJ, Bunker CH, Kelsey SF, Lloyd CE, Drash AL, Kuller LH, Orchard TJ. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 1993; 16: 1376-1383.
6. Muhlhauser I, Bender R, Bott U, Jorgens V, Grusser M, Wagener W, Overmann H, Berger M. Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes. Diabet Med 1996; 13: 536-543.
7. Miller JA. Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus. J Am Soc Nephrol 1999; 10: 1778-1785.
8. Cherney DZ, Sochett EB, Miller JA. Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes. Kidney Int 2005; 68: 1722-1728.
9. Ahimastos AA, Formosa M, Dart AM, Kingwell BA. Gender differences in large artery stiffness pre-and post puberty. J Clin Endocrinol Metab 2003; 88: 5375-5380.
10. Ryden Ahlgren A, Lanne T, Wollmer P, Sonesson B, Hansen F, Sundkvist G. Increased arterial stiffness in women, but not in men, with IDDM. Diabetologia 1995; 38: 1082-1089.
11. Ahlgren AR, Sundkvist G, Sandgren T, Lanne T. Female gender increases stiffness of elastic but not of muscular arteries in type I diabetic patients. Clin Physiol Funct Imaging 2002; 22: 409-415.
12. Protogerou AD, Blacher J, Aslangul E, Le Jeunne C, Lekakis J, Mavrikakis M, Safar ME. Gender influence on metabolic syndrome's effects on arterial stiffness and pressure wave reflections in treated hypertensive subjects. Atherosclerosis 2007; 193: 151-158.
13. Pechere-Bertschi A, Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens 2004; 17: 994-1001.
14. Cherney DZI, Scholey JW, Sochett EB. Sex differences in renal responses to hyperglycemia, L-arginine and L-NMMA in humans with uncomplicated type 1 diabetes mellitus. Diabetes Care 2013; 36: 1290-1296.
15. Cherney DZ, Scholey JW, Jiang S, Har R, Lai V, Sochett EB, Reich HN. The Effect of Direct Renin Inhibition Alone and in Combination With ACE Inhibition on Endothelial Function, Arterial Stiffness, and Renal Function in Type 1 Diabetes. Diabetes Care 2012; 35: 2324-2330.
16. Cherney DZ, Reich HN, Scholey JW, Lai V, Slorach C, Zinman B, Bradley TJ. Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cbeta inhibition and renin-angiotensin system blockade: a pilot study. Can J Physiol Pharmacol 2012; 90: 113-121.
17. Sochett EB, Cherney DZ, Curtis JR, Dekker MG, Scholey JW, Miller JA. Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes. J Am Soc Nephrol 2006; 17: 1703-1709.
18. Cherney DZ, Reich HN, Miller JA, Lai V, Zinman B, Dekker MG, Bradley TJ, Scholey JW, Sochett EB. Age is a determinant of acute hemodynamic responses to hyperglycemia and angiotensin II in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 2010; 299: R206-R214.
19. Cherney DZ, Reich HN, Jiang S, Har R, Nasrallah R, Hebert RL, Lai V, Scholey JW, Sochett EB. Hyperfiltration and the effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 2012; 303: R710-R718.
20. Cherney DZ, Lai V, Scholey JW, Miller JA, Zinman B, Reich HN. Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study. Diabetes Care 2010; 33: 361-365.
21. Sasson AN, Cherney DZ. Renal hyperfiltration related to diabetes mellitus and obesity in human disease. World J Diabetes 2012; 3: 1-6.
22. Cherney D, Montanari A. The effect of gender on arterial stiffness responses to hyperglycemia in type 1 diabetes mellitus. Clinical and Experimental Hypertension 2013 (in press).
23. Cherney DZI, Scholey JW, Sochett EB. Gender differences in renal responses to hyperglycemia, L-arginine and L-NMMA in humans with uncomplicated type 1 diabetes mellitus. Diabetes Care 2012; 36: 1290-1296.
24. Seals DR, Moreau KL, Gates PE, Eskurza I. Modulatory influences on ageing of the vasculature in healthy humans. Exp Gerontol 2006; 41: 501-507.
25. Dengel DR, Goldberg AP, Mayuga RS, Kairis GM, Weir MR. Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension 1996; 28: 127-132.
26. Levenson J, Pessana F, Gariepy J, Armentano R, Simon A. Gender differences in wall shear-mediated brachial artery vasoconstriction and vasodilation. J Am Coll Cardiol 2001; 38: 1668-1674.
27. Perregaux D, Chaudhuri A, Mohanty P, Bukhari L, Wilson MF, Sung BH, Dandona P. Effect of gender differences and estrogen replacement therapy on vascular reactivity. Metabolism 1999; 48: 227-232.
28. Kawano H, Motoyama T, Kugiyama K, Hirashima O, Ohgushi M, Fujii H, Ogawa H, Yasue H. Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. J Am Coll Cardiol 1997; 30: 914-919.
29. New G, Timmins KL, Duffy SJ, Tran BT, O'Brien RC, Harper RW, Meredith IT. Long-term estrogen therapy improves vascular function in male to female transsexuals. J Am Coll Cardiol 1997; 29: 1437-1444.
30. Darkow DJ, Lu L, White RE. Estrogen relaxation of coronary artery smooth muscle is mediated by nitric oxide and cGMP. Am J Physiol 1997; 272: H2765-H2773.
31. Dietz NM. Gender and nitric oxide-mediated vasodilation in humans. Lupus 1999; 8: 402-408.
32. Schneider MP, Ritt M, Raff U, Ott C, Schmieder RE. Gender is related to alterations of renal endothelial function in type 2 diabetes. Nephrol Dial Transplant 2009; 24: 3354-3359.
33. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801-1811.
34. Akishita M, Kozaki K, Eto M, Yoshizumi M, Ishikawa M, Toba K, Orimo H, Ouchi Y. Estrogen attenuates endothelin-1 production by bovine endothelial cells via estrogen receptor. Biochem Biophys Res Commun 1998; 251: 17-21.
35. Seely EW, Walsh BW, Gerhard MD, Williams GH. Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women. Hypertension 1999; 33: 1190-1194.
36. Oelkers WK. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 1996; 61: 166-171.
37. Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 2004; 286: R233-R249.
38. Reckelhoff JF, Zhang H, Granger JP. Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension 1998; 31: 435-439.
39. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension 2001; 37: 1199-1208.
40. Costarella CE, Stallone JN, Rutecki GW, Whittier FC. Testosterone causes direct relaxation of rat thoracic aorta. J Pharmacol Exp Ther 1996; 277: 34-39.
41. Arcaro G, Zenere BM, Saggiani F, Zenti MG, Monauni T, Lechi A, Muggeo M, Bonadonna RC. ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care 1999; 22: 1536-1542.
42. Liu HW, Iwai M, Takeda-Matsubara Y, Wu L, Li JM, Okumura M, Cui TX, Horiuchi M. Effect of estrogen and AT1 receptor blocker on neointima formation. Hypertension 2002; 40: 451-457.
43. Ruggenenti P, Perna A, Zoccali C, Gherardi G, Benini R, Testa A, Remuzzi G. Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen). J Am Soc Nephrol 2000; 11: 88-96.
44. Ichikawa J, Sumino H, Ichikawa S, Ozaki M. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women. Am J Hypertens 2006; 19: 744-749.